Pantarhei’s objective is to develop and out-license patent protected concepts with clinically proven feasibility and safety (phase II) to pharmaceutical companies for final clinical development (phase III) and commercialisation.
For detailed information, please contact:
Carole Verhoeven, PhD: Estetrol
Yvette Zimmerman, PhD: Androgen Restored Contraception (ARC) and Zona Pellucida (ZP)
phone: + 31 (0)30 69 85 020